Showing results (11-20 of 197) with videos related to
Sort By:
Pageof 20
Expert Review of Anticancer Therapy|October 18, 2011
Raltitrexed in mesotheliomaVeerle F Surmont, Jan P van MeerbeeckPolskie Archiwum Medycyny Wewnetrznej|December 24, 2010
European guidelines for the management of malignant pleural mesotheliomaEric van Thiel, Jan P van MeerbeeckCurrent Opinion in Oncology|February 3, 2007
Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancerRebecca De Pauw, Jan P van MeerbeeckJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
Surgery in mesothelioma--where do we go after MARS?Birgitta I Hiddinga, Jan P van MeerbeeckJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Malignant mediastinal tumor with bone formation--mesothelioma or sarcoma?Gunnar Hillerdal, Göran ElmbergerJournal of Thoracic Disease|August 18, 2020
Intrabronchial stents in heterogenous emphysema: a highly selected material followed 5 yearsGunnar Hillerdal, Hirsh KoyiRespiratory Medicine|July 5, 2005
Hemoptysis and coughing up of staples as a late complication of volume reduction surgery for emphysemaGunnar Hillerdal, Lotta OrreRespiration; International Review of Thoracic Diseases|September 18, 2014
One- to four-year follow-up of endobronchial lung volume reduction in alpha-1-antitrypsin deficiency patients: a case seriesGunnar Hillerdal, Stephanie MindusLung Cancer (Amsterdam, Netherlands)|March 17, 2009
Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developmentsJan P van Meerbeeck, Veerle F M SurmontCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 8, 2014
Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesisKevin Lamote, Kristiaan Nackaerts, Jan P van MeerbeeckPageof 20